Skip to main content

is part of the Informa Markets Division of Informa PLC

  • INFORMA PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CPHI North America
 
Please enter alphanumeric values only!
    • Sign-Out
    • My Profile
  • Select Events By Region
    • Barcelona
    • China
    • India
    • Japan
    • Korea
    • Middle East
    • North America
    • South East Asia
    • Pharmapack

CPHI ONLINE

AWARDS

May, 7-9, 2024

Pennsylvania Convention Center, Philadelphia

EXHIBIT IN 2024
img-responsive
REGISTER YOUR INTEREST
img-responsive
  • HOME
  • ATTEND
    • Why attend
    • Register your Interest
      • Thank You Page
    • Hotel & Travel
    • Essential Information
  • 2024 EXHIBITORS
  • EXHIBIT
    • Why Exhibit
    • Contact the Sales Team
    • DOWNLOAD EXHIBITOR PROSPECTUS
    • Digital Solutions
    • Sponsorship Options
    • Exhibitor FAQ
    • Official Vendors
    • Connections Program
    • Exhibitor warning
    • 2024 Call For Speakers
  • ABOUT
    • Partners
    • Contact Us
  • Home
  • EXHIBIT
  • Show Sectors
  • Ingredients & Integrated Pharma

CPhI Zone at CPhI North America

Meet the Leaders in APIs and Excipients

The trends in ingredient manufacturing are undeniable. A growing market for innovative APIs, generics, and bio coupled with improved awareness for the environment, more sustainable ingredients, and better waste management are transforming the landscape. All this means incredible opportunity to expand business globally—and the CPhI Manufacturing and Ingredients Zone is where you’ll make it happen.

Global pharmaceutical sales are expected to grow at CAGR of 3% - 6% with High-potency APIs (HPAPIs) and Generic APIs leading the way.

The global active pharmaceutical ingredient market is estimated to reach $186 billion by 2020.

There is a rise in the global burden of chronic and lifestyle diseases increasing utilization of parenteral products.

Healthcare policy-makers and payers are increasingly mandating what doctors can prescribe. Governments are beginning to focus on prevention rather than treatment.

News & Updates


Report: US Pharma Market 2022 and Beyond

Report: US Pharma Market 2022 and Beyond

First-of-its-kind Alzheimer’s drug gains US FDA approval

First-of-its-kind Alzheimer’s drug gains US FDA approval

See all news

Contact Us




Attendee Questions:
[email protected]


Interested in Exhibiting?
[email protected]


Already an Exhibitor, but have a question?
[email protected]

Caution - Exhibitors


Beware of unsolicited websites and companies.

Follow Us


Informa Markets

Copyright © 2023. All rights reserved. Informa Markets, a trading division of Informa PLC.

  • Accessibility|
  • Privacy Policy |
  • Cookie Policy|
  • Terms of Use|
  • Visitor Terms And Conditions